Inflammatory Bowel Disease Center Is Launched
Thomas Jefferson University Hospital has established a comprehensive
center for diagnosing and treating inflammatory bowel disease. The Jefferson
Inflammatory Bowel Disease Center provides care for people with Crohn's
disease, ulcerative colitis, collagenous colitis and microscopic colitis.
New treatments utilizing proven investigational drugs and drug programs
are available for patients who have failed conventional therapy. The Acting
Director of the Center is Franz Goldstein, MD, Professor of Medicine and
a nationally renowned clinician and researcher on inflammatory bowel disorders.
"We are fortunate that someone of Dr. Goldstein's stature is devoting
his interest and time to the Center," says Anthony J. DiMarino Jr.,
MD, Director of the Division of Gastroenterology and Hepatology. "The
other members of our team also bring years of experience, giving us more
expertise in inflammatory bowel disease than any other hospital in the area."
Since there is no labeled, approved drug treatment for Crohn's disease,
accept for steroids to get patients through acute crises, many physicians
are afraid to prescribe effective drugs. The existence of so many clinical
variants further complicates recognition and effective treatment.
"There are an estimated one to two million people in the United States
who suffer from inflammatory bowel diseases. Crohn's and ulcerative colitis
are potentially devastating, life-threatening diseases, and require a lot
of attention. There is no simple dietary or surgical solution," says
Dr. Goldstein. The average patient with Crohn's disease goes two to three
years before a proper diagnosis is made because many physicians often are
not familiar with the symptomatology which can be subtle and crosses many
The Center's 20 physicians include experts from the Division of Gastroenterology
and Hepatology, as well as general and colorectal surgery. Specialists in
radiology, pathology, genetics, nutrition and other disciplines provide
consultation. A psychiatrist assists in helping patients cope with this
unpredictable and sometimes frightening chronic illness, which can affect
the skin, bones and eyes as well as the urinary tract, bowels and liver.
Dr. Goldstein has been affiliated with Jefferson for the last 40 years.
He was awarded a mastership from the American College of Gastroenterology
and has authored more than 130 articles. Responsible for many "firsts"
in the field, Dr. Goldstein was nominated by colleagues as one of the "Best
Doctors in the Northeast" for inflammatory bowel disease, along with
three other physicians at the Center - four more physicians in this specialty
than at any other Philadelphia hospital.
The Inflammatory Bowel Disease Center offers one-time evaluation, second
opinions and long-term maintenance treatment. It is located in the Main
Building, 132 South 10th Street, Suite 480. For further information or to
make an appointment, call 5-1700 or 1-800-JEFF-NOW.